EDWARDS LIFESCIENCES CORP (EW:NYSE)
$90.82 0.26 (0.2871%)
Analysed EDWARDS LIFESCIENCES CORP (EW:NYSE) News Sources
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
01-10-2026
yahoo.com
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
05-10-2026
yahoo.com
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
07-10-2026
yahoo.com
Edwards Lifesciences Earnings Preview: What to Expect
12-10-2026
barchart.com
Edwards’ SAPIEN M3 delivery system linked to patient death in FDA alert
16-10-2026
medicaldevice-network.com
FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death
16-10-2026
yahoo.com
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
21-10-2026
yahoo.com
Edwards secures FDA approval for tricuspid valve repair system
22-10-2026
medicaldevice-network.com
Edwards wins FDA approval for tricuspid valve repair device
23-10-2026
medtechdive.com
Does Valve Repair Approval Change The Bull Case For Edwards Lifesciences (EW)?
23-10-2026
yahoo.com
What is the current price of EDWARDS LIFESCIENCES CORP (EW:NYSE)?
The current price of EDWARDS LIFESCIENCES CORP (EW:NYSE) is $90.82.
EDWARDS LIFESCIENCES CORP (EW:NYSE) absolute price change since previous trading day?
The absolute price change of EDWARDS LIFESCIENCES CORP (EW:NYSE) since the previous trading day is $0.26.
EDWARDS LIFESCIENCES CORP (EW:NYSE) percentage price change since previous trading day?
The percentage price change of EDWARDS LIFESCIENCES CORP (EW:NYSE) since the previous trading day is 0.2871%.
What is the most recent average sentiment score for EDWARDS LIFESCIENCES CORP (EW:NYSE)?
The most recent average sentiment score for EDWARDS LIFESCIENCES CORP (EW:NYSE) is 67 out of 100.
What is the most recent average sentiment for EDWARDS LIFESCIENCES CORP (EW:NYSE)?
The most recent sentiment for EDWARDS LIFESCIENCES CORP (EW:NYSE) is .
SEC-8K** Filing Available For EDWARDS LIFESCIENCES CORP (EW:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.